http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2392862-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04fb02190dac07816f88ecd6aa997e95 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43b7f99a03f90ba4fb749044e4333bd |
publicationDate | 2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2392862-B1 |
titleOfInvention | TGF-BETA AND / OR SMAD3 AS MARKERS OF DIAGNOSIS AND / OR FORECAST OF ALPHA-SINUCLEINOPATHIES |
abstract | TGF {be} and / or Smad3 as diagnostic and / or prognostic markers of {al} -synucleinopathies. # The present invention relates to a method for the diagnosis and / or prognosis of {al} -synucleinopathies in a sample obtained from a patient comprising determining the level of expression of the TGF {be} and / or Smad3 gene and / or the activity of the protein encoded by said gene and comparing said level with a control value, where the alteration of said level is indicative of { al} -synucleinopathy. |
priorityDate | 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.